News from NYU Langone Health
Brookhaven town board approves $650M hospital expansion, modernization project in Patchogue
News 12 Long Island
The Brookhaven Town Board unanimously approved a $650 million investment to expand and modernize NYU Langone Hospital—Suffolk in Patchogue. The project includes a new seven-story, 144-bed pavilion for medical, surgical, and intensive care. NYU Langone Health fully integrated the hospital last spring. A spokesperson for NYU Langone Health expressed gratitude for the town's approval, highlighting it as a significant step for healthcare in Suffolk County. Construction is expected to take over three years.
8/27/2026
NYU Langone Health announces 'major leadership transition'
Diagnostic and Interventional Cardiology
NYU Langone Health has appointed Sunil Rao, MD, as the new director of the Leon H. Charney Division of Cardiology, effective 1 September. He succeeds Glenn I. Fishman, MD, who is stepping down after a 25-year tenure. The health system also announced that Susheel K. Kodali, MD, will join NYU Langone as director of interventional cardiology and director of its Cardiac Catheterization Laboratory in Manhattan. Kodali comes from NewYork-Presbyterian/Columbia University Irving Medical Center. Alec Kimmelman, MD, PhD, dean of NYU Grossman School of Medicine and CEO of NYU Langone Health, praised the appointments and Dr. Fishman's lasting impact.
8/27/2026
22 Long Island hospitals recognized for heart, stroke care
Newsday
NYU Langone Hospital—Long Island and NYU Langone Hospital—Suffolk have been recognized by the American Heart Association (AHA) for improving heart disease and stroke. Levi Dygert, MD, medical director of vascular neurology at NYU Langone’s two Long Island hospitals, said the recognition underscores that patients on Long Island can expect fast expert evidence-based stroke care close to home when every second counts.
8/28/2026
Busy Philipps' brain tumor revealed through a Prenuvo MRI
NewsNation
Actress Busy Philipps was diagnosed with a rare brain tumor following a Prenuvo full-body MRI scan that revealed a lesion. Her follow-up MRI was reviewed by Orrin Devinsky, MD, professor in NYU Langone's Departments of Neurology, Neurosurgery, and Psychiatry, who diagnosed a grade 2 oligodendroglioma and recommended surgery. Philipps underwent a successful procedure on March 2 to remove the tumor. The article also notes potential downsides of full-body screening, such as overdiagnosis and high costs. Doctors stated that early detection before symptoms appeared allowed for an easier surgical removal of the tumor.
8/27/2026
Busy Philipps reveals rare brain tumor diagnosis: 'I'm grateful that I'm alive'
The State
Actress Busy Philipps revealed her diagnosis with a rare, grade 2 oligodendroglioma brain tumor, which was discovered during a full-body MRI. After the initial scan showed a lesion on her brain, a follow-up MRI was reviewed by a neurologist at NYU Langone, who confirmed it was a tumor that required surgical removal. Philipps underwent a five-hour surgery in March to remove the mass, followed by a second procedure in April to treat a staph infection at the incision site. She does not currently require chemotherapy or radiation but will have regular scans.
8/27/2026
Joe Amabile shares brain tumor diagnosis discovered at NYU Langone
GMA First Look
Bachelor in Paradise star Joe Amabile, widely known as "Grocery Store Joe," has revealed an unexpected brain tumor diagnosis discovered during an elective full-body MRI. Doctors identified a marble-sized lesion in his left frontal lobe, a region critical for memory, speech, and motor skills. Amabile noted that his physician informed him he likely would not have known about the condition until it triggered a seizure. Follow-up scans at NYU Langone Health pointed toward a type of tumor called an astrocytoma.
8/28/2026
Delaying dementia through mid-life health management
Fox News Radio - House Call for Health
Josef Coresh, MD, PhD, the founding director of the Optimal Aging Institute and the Terry and Mel Karmazin Professor of Population Health at NYU Grossman School of Medicine, served as the senior investigator for a study published in Neurology Open-access. The research reveals that avoiding smoking, high blood pressure, and diabetes between the ages of 48 and 68 can provide up to 13 additional years without dementia. Dr. Coresh stresses that managing these vascular factors in mid-life is a vital strategy for preserving brain health, offering an actionable way to stall memory loss for a population where 42% of Americans are projected to develop the condition after age 55.
8/27/2026
GLP-1s may have a host of other health benefits. Just ask these people
USA Today
GLP-1-based medications, initially for diabetes and obesity, are being studied for broader health benefits related to the heart, kidneys, and liver. Melanie Jay, MD, professor, Departments of Medicine and Population Health at NYU Grossman School of Medicine, explains that weight loss from the drugs can lead to improvements by reducing inflammation and easing organ pressure. She notes there are likely both weight-dependent and independent effects. Dr. Jay adds that large trials show treating obesity can prevent major negative health outcomes, with strong evidence for sleep apnea and kidney disease, but urges caution on claims about addiction and cancer.
8/27/2026
How to learn to live with grief—and make room for joy
Women's Health
In a podcast episode examining grief, Amanda Kloots discusses her personal journey after her husband's death. She is joined by Thea Gallagher, PsyD, director of wellness programs and clinical associate professor of psychiatry at NYU Langone Health. Dr. Gallagher offers clinical insights, explaining that people in 'survival mode' prioritize immediate steps and process trauma later. She also discusses affective forecasting, noting people are often more resilient than they anticipate. Dr. Gallagher advises that feeling guilt while moving forward is normal and recommends therapy and community support for those questioning how to handle their grief.
Also reporting was: Yahoo Life, Aol, MSN
8/27/2026
What is postpartum psychosis, the condition central to the trial of Lindsay Clancy?
The Guardian
Postpartum psychosis, a rare but severe mental health illness, is the focus of the trial of Lindsay Clancy, who is accused of killing her three children. The condition can cause hallucinations, delusions, and mood changes, and is considered a psychiatric emergency. Bonnie Kerker, PhD, a professor of population health and child and adolescent psychiatry at the NYU Grossman School of Medicine, notes that postpartum psychosis is at the far end of the perinatal mental health spectrum. She adds that myths surrounding the postpartum period can lead to women ignoring symptoms and refusing to seek help.
Also reporting was: AOL UK, Yahoo Health
8/27/2026
APAO 2026: Jennifer Fisher on multimodal care for brain metastases
Oncology Nursing News
At the Association of PAs in Oncology symposium, Jennifer Fisher, a physician assistant at NYU Langone Health, highlighted that a multimodal approach is most effective for managing brain metastases. Fisher explained that combining advanced radiation, surgery, and novel systemic therapies with better central nervous system penetration is transforming patient outcomes. She noted that these integrated strategies are challenging historical prognoses that viewed the diagnosis as a terminal event. This approach is resulting in prolonged survivorship and improved quality of life for patients with complex secondary brain tumors.
8/27/2026
Can technology make pathology more human? Part 1
The Pathologist
In a panel discussion on the future of pathology, Syed Hoda, MD, clinical professor, director of Bone and Soft Tissue Pathology at NYU Langone Health, and director of Surgical Pathology at NYU Langone Orthopedic Hospital, advocated for a cultural change within the specialty. He argued that pathologists must become more visible and engaged to redefine their role alongside artificial intelligence. Hoda suggested that AI's greatest potential is in improving laboratory work and quality assurance, rather than just increasing diagnostic speed. He warned that focusing only on efficiency could make the profession less connected and that AI should be used to foster a broader, more human professional transformation.
8/27/2026
FDA approves ‘game-changing’ pancreatic cancer drug
TODAY
The FDA has approved Rasonque, a daily pill for pancreatic cancer that doubled survival time in clinical trials when compared to chemotherapy alone. As an NBC medical contributor, Natalie Azar, MD, clinical associate professor in NYU Langone's Department of Medicine, commented on the approval, noting that the drug targets a protein that has challenged scientists for decades.
8/27/2026
Research shows short walking breaks may help control blood sugar after meals
Health
A new analysis of over 30 studies indicates that taking short walking breaks can help control post-meal blood sugar spikes. The research found that just a few minutes of movement throughout the day, particularly walking, were associated with lower glucose and insulin responses compared to uninterrupted sitting. People who moved at least every 30 minutes saw the most benefit. Rachel Pessah-Pollack, MD, clinical professor of medicine at NYU Langone Health’s Holman Division of Endocrinology, Diabetes & Metabolism, noted that these findings align with existing recommendations from the American Diabetes Association for regulating glucose levels.
Also reporting was: Aol
8/27/2026
What’s in a name? Experts debate pros, cons of PCOS name change
Healio Women’s Health & OB/GYN
Experts are debating the recent name change of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). While some specialists believe the new name better reflects the condition's hormonal and metabolic aspects, others, including those at Mount Sinai, argue it is not comprehensive. Contributing to the discussion, Harmony Reynolds, MD, director of the Sarah Ross Soter Center for Women’s Cardiovascular Research at NYU Langone Health, noted that PMOS is considered a female-specific risk factor in dyslipidemia guidelines. She stated the diagnosis could influence decisions to treat high LDL cholesterol and should be incorporated into preventive care by primary care providers.
8/27/2026
Multi-academic study finds no link between pesticide exposure and autism traits
Genetic Engineering & Biotechnology News
A study led by NYU Langone Health researchers found no significant link between prenatal exposure to certain agricultural insecticides and autism-related traits in children. The research, published in JAMA Pediatrics, analyzed over 3,300 mother-child pairs. According to lead author Haleigh Cavalier, PhD, a former doctoral student at NYU Grossman School of Medicine, the pesticides were not a major driver of autism traits at low exposures. Senior author Akhgar Ghassabian, MD, PhD, associate professor in the Departments of Pediatrics and Population Health at NYU Grossman School of Medicine, noted more research is needed on environmental factors.
8/27/2026
U.S. Physical Therapy bets on hospital alliances to drive visits, reimbursement
MarketBeat
U.S. Physical Therapy is pursuing growth through a hospital-alliance strategy, highlighting its 10-year relationship with NYU Langone as a major initiative. The company's 60 regional locations are now integrated into NYU Langone's ambulatory network. Under this exclusive arrangement, U.S. Physical Therapy functions as a contracted provider using its own employees and facilities, receiving a flat per-visit payment from NYU Langone. According to CEO Chris Reading, this model allows the company to bill at the hospital system's rates, yielding higher reimbursement and protecting against rising clinical employee costs while supporting significant growth.
Also reporting was: Yahoo Finance
8/27/2026
